Venetoclax–azacitidine as a bridge to transplant in pediatric relapsed/refractory acute myeloid leukemia: A real-world experience
Background: Survival outcomes in pediatric acute myeloid leukemia (AML) have improved significantly; however, prognosis for relapsed or refractory (R/R) disease remains dismal. This study evaluates real-world outcomes of Venetoclax-Azacytidine (Ven–Aza) as a bridge to transplant in children with R/R...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2026-06-01
|
| シリーズ: | Pediatric Hematology Oncology Journal |
| 主題: | |
| オンライン・アクセス: | http://www.sciencedirect.com/science/article/pii/S2468124526000355 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
